Bessemer Group Inc. Sells 2,598 Shares of CME Group Inc. $CME

Bessemer Group Inc. trimmed its position in CME Group Inc. (NASDAQ:CME) by 0.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 913,859 shares of the financial services provider’s stock after selling 2,598 shares during the quarter. Bessemer Group Inc. owned approximately 0.25% of CME Group worth $246,915,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Jessup Wealth Management Inc increased its holdings in shares of CME Group by 0.5% during the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after acquiring an additional 36 shares during the last quarter. First Horizon Advisors Inc. boosted its position in CME Group by 0.7% during the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after purchasing an additional 36 shares during the period. MBM Wealth Consultants LLC increased its holdings in shares of CME Group by 2.7% in the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after purchasing an additional 37 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its holdings in shares of CME Group by 0.8% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock valued at $1,384,000 after purchasing an additional 38 shares during the last quarter. Finally, Atlatl Advisers LLC raised its position in shares of CME Group by 1.8% in the third quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after purchasing an additional 38 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Up 0.5%

Shares of NASDAQ:CME opened at $294.62 on Thursday. The business’s 50 day simple moving average is $276.15 and its 200 day simple moving average is $272.67. CME Group Inc. has a 1 year low of $239.70 and a 1 year high of $296.76. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $106.24 billion, a P/E ratio of 28.55, a P/E/G ratio of 3.30 and a beta of 0.27.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the company posted $2.52 EPS. The company’s revenue was up 8.1% compared to the same quarter last year. On average, research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

Insider Transactions at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares of the company’s stock, valued at $17,737,468.20. This trade represents a 27.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard purchased 251 shares of the business’s stock in a transaction dated Tuesday, December 30th. The shares were purchased at an average cost of $278.37 per share, with a total value of $69,870.87. Following the acquisition, the director owned 258,710 shares in the company, valued at $72,017,102.70. This trade represents a 0.10% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on CME. Jefferies Financial Group decreased their price target on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a research note on Monday, January 12th. Royal Bank Of Canada upped their target price on CME Group from $282.00 to $295.00 and gave the company a “sector perform” rating in a research report on Friday, December 5th. UBS Group reissued a “neutral” rating on shares of CME Group in a report on Tuesday, January 6th. TD Cowen raised CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. Finally, JPMorgan Chase & Co. increased their price objective on CME Group from $256.00 to $262.00 and gave the stock an “underweight” rating in a research report on Thursday, January 22nd. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus price target of $292.18.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 results beat and record annual metrics — CME reported Q4 non‑GAAP EPS of $2.77 (vs. ~$2.75 est.) and revenue around $1.65B; management said 2025 produced record annual revenue and adjusted earnings. This confirms durable profitability and supports the rally. PR Newswire: CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue…
• Positive Sentiment: Record trading volumes/ADV — January set a record 29.6M contracts (up 15% YoY) and the company reported its highest-ever ADV in several product categories, boosting fee-related revenue. Strong volumes underpin near-term revenue growth. PR Newswire: CME Group January Volume Sets New Record…
• Positive Sentiment: Guidance and product expansion — Management targets a 1%–1.5% revenue lift from fee adjustments and is expanding 24/7 crypto and securities clearing, which could open new fee pools and justify multiple expansion if uptake continues. MSN: CME Group targets 1%–1.5% revenue lift…
• Positive Sentiment: Macro/flow tailwinds — Reuters and other outlets noted higher hedging demand lifted trading activity and profit, reinforcing that market structure and client flows are supporting revenue this quarter. Reuters: Derivatives exchange CME’s profit rises as hedging demand lifts trading volume
• Neutral Sentiment: Exploring a proprietary token and tokenized cash pilot — CEO Terry Duffy said CME is studying a CME‑issued token and is piloting tokenized cash infrastructure with Google. This signals strategic optionality into tokenization but also introduces regulatory and execution uncertainty. Cointelegraph: CME CEO Duffy says exchange is exploring issuing its own token
• Neutral Sentiment: Analyst coverage and targets generally supportive — multiple firms maintain buy/overweight ratings and median price targets sit above current levels, which can prop up sentiment but are not guarantees of upside. QuiverQuant: CME Releases Q4 2025 Earnings (includes analyst notes)
• Negative Sentiment: Insider selling activity — filings show notable insider sales in recent months, which can be read as a modest negative signal for sentiment even though institutional holdings remain large. QuiverQuant: CME Releases Q4 2025 Earnings (insider transaction details)

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.